-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - included observational studies and open-label followup
extensions of RCTs reporting long-term (>6 months … Followup duration ranged
from 6 months to 10 years. … to 60 subjects)
found no difference versus placebo at 12 months in
mean change in IRLS scale scores … No RCTs assessed patients with mild or
moderate disease, and few lasted longer than 6 months. … Efficacy and
augmentation during 6 months of double-blind pramipexole for
restless legs syndrome.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
September 06, 2023 - Since the last update, there are also emergent paradigm changes that should be
recognized. … A key debate in the field in the last decade centers around equity, social
determinants of health, and … The dispositions of the peer review comments are documented
and may be published three months after
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_disposition-comments.pdf
August 21, 2013 - responses to the comments are posted for
public viewing on the EHC Program Web site approximately 3 months … – it was 9.5 months – given that
it was jail study 9.5 years does not make logical sense). … Results: yes to all of the above except the last question. Thank you. … No to the last question because overcoming the barriers to
such research has not been adequately addressed … This population is held anywhere from a
few days to a few months.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
January 01, 2022 - In
patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to
<6 months) … 2
Background and Purpose
Chronic pain is defined as pain lasting longer than 3 to 6 months … : Benefits of cannabinoids for chronic pain compared with placebo in the
short term (4 weeks to <6 months … Question 2: Harms of cannabinoids for chronic pain compared with placebo in the
short term (4 weeks to <6 months
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - Treatment of DPN symptoms (pain, paresthesias, numbness)
Diabetic peripheral neuropathy was last covered … studies, case series, case reports, and
meeting abstracts
Timing Studies for KQ1a must have at least 3 months … and for areas where high-quality reviews
exist in English, will identify and assess recent relevant (last … We will also hand search other recent (last 5 years) relevant reviews to identify any
additional articles … The
disposition of comments for systematic reviews and technical briefs will be published three
months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
August 01, 2014 - , social communication and interaction, restricted
and repetitive behaviors) in the short term (≤6 months … symptoms (e.g., motor, medical, mood/anxiety,
irritability, and hyperactivity) in the short term
(≤6 months … 3
KQ 1c: What are the longer term effects (>6 months)
on core symptoms (e.g., social communication … KQ 1d: What are the longer term effects (>6 months)
on commonly associated symptoms (e.g., motor,
medical … Our
last search was conducted in December 2013.
-
effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - responses to the comments are posted for
public viewing on the EHC Program Web site approximately 3 months … authors describe the disparity subgroups in paragraph 3 and once
again describe the subgroups in the last … With
that said, however, this second to last paragraph on page 25 is
redundant to what is in the Methods … paragraph of page 35;
last paragraph on page 41; first paragraph on page 42). … You
have taken a wide range of data over the last 35 years and sifted
through many publications to
-
effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
January 01, 2013 - predictive value, when possible
Support the unit of analysis chosen for exposure measurement (e.g., person-months … operationalizing exposure to these two medications, it would be insufficient to examine medication use in the last … The last column (G–I) represents scenarios where there are multiple exposures over time with different … accurate definitions available
Support the unit of analysis chosen for exposure measurement (e.g., person-months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
May 01, 2025 - as 55% of solid
organ transplant recipients experiencing at least one infection within the first 12 months … vulnerable to infections due to the
immunosuppression required to prevent transplant rejection, which can last … Results were limited to English
language studies on human participants and covered publications from the last … Patients in the treatment group used the
oral mucosal protectant twice daily for three months. … In fact, some guidelines suggest avoiding any dental treatment for at least three months post-
transplant
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
January 01, 2012 - depending on expert comments received on interventions issued for comment during the
preceding 6 months … norepinephrine-releasing drug that was approved by FDA
in 1959 as an appetite suppressant for short-term (3 months … with a decision date set for April 17, 2012.
8
In April 2012, FDA extended the decision
date three months … Administration for inclusion in its therapeutic goods registry for treating T2DM
and obesity for up to 12 months … implantation, a mean excess weight loss of
29.8%, reduction of HbA1c from 8.4% at baseline to 7.0% after 6 months
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_consumer.pdf
January 01, 2017 - Over time, attacks may last longer
and may happen more often. … Allopurinol (Zyloprim®) and febuxostat (Uloric®) do not lower the
risk of a gout attack in the first 6 months
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - depending on expert comments received on interventions issued for
comment during the preceding 6 months … Topics tracked since the last Potential High-Impact
Interventions Report include an intranasal naloxone … Additionally, after 3 months, patients in the SA+F group had significantly greater reductions in total … : -14.5 percentage points) than either SA (baseline: 78.1%; 3 months: 75.0%; change: -3.1
percentage … Six-months outcomes of a randomised trial of
supportive text messaging for depression and
comorbid
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
August 23, 2010 - We plan to restrict our search to literature published within
the last 10 years as the modalities of … literature searches, as this is a project that will be
completed in a relatively short time frame (7 months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
February 01, 2014 - We looked for data on these outcomes at the last
reported time point. … Asian,24 and
7 percent unspecified other race.25 The mean or median
disease duration ranged from 7 months … and reported on the IBDQ among patients
who had undergone ileocolonic anastomosis within 6 to
24 months … The length of
followup ranged from 8 weeks to 18 months for RCTs and
up to 3.6 years in an observational … The longest RCT had only 18 months of
followup, and the longest prospective study had less than 4
years
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - ), intermediate-term treatment duration (6 to <12 months), and long-
term treatment duration (≥12 months … ),
intermediate-term treatment duration (6 to <12 months), and long-term
treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months),
and long-term treatment duration (≥12 months … ),
intermediate-term treatment duration (6 to <12 months), and long-
term treatment duration (≥12 months … 12 months), and long-term treatment duration (≥12 months)
• We will assess available literature to
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
June 09, 2021 - than pre or post surgery to be more
inclusive of non-operative trials-Bullet point 8:
Would rephrase last … Page 10, last paragraph. Two few studies for
testing for publication bias. … Page 18, last paragraph. … in
the abstract and at 12 months among long-term
survivors. … The last few statements on p. 50 were
especially salient to this topic.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
December 01, 2024 - assigned staff were undertrained
on data)
• Timeline (front-end data requisition and access
required months … Content last reviewed November
2023. Agency for Healthcare Research and
Quality. Rockville, MD. … Content last reviewed December 2022.
Agency for Healthcare Research and
Quality. Rockville, MD.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_disposition-comments.pdf
January 01, 2012 - responses to the comments are posted for
public viewing on the EHC Program Web site approximately 3 months … Thank you
Mehul Dalal
(Public
Reviewer)
Introduction Abstract Pg ix – “Data Synthesis” 2nd to last … and
Discussion
Pg 118 – “Interpretation of findings of Key Questions 1 and 2” first
paragraph, last … Suggest modifying the last sentence
of this paragraph to reflect this point. … Pg 121 – last paragraph, last sentence • Suggest adding “race and
ethnicity” as candidate variable of
-
effectivehealthcare.ahrq.gov/sites/default/files/transcript_deliberativemethodswebinar.pdf
April 19, 2012 - The last topic will provide an overview of the deliberation
experiment taking place as part of AHRQ … Goold’s last point about sort of how the
diversity really enhances the deliberations because the … single events or have a longer duration where
deliberations may take place over several weeks or months … actually have the benefit of having a
set of meetings that might take place over several weeks or
months … review, which I
mentioned, I hope you will please look for a piece based on
this within the next few months
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
July 01, 2009 - prototype currently captures, codifies and standardizes over 150
unique data elements per patient for 48 months … In the last month how many times have you needed to eat or drink something because you felt your blood … Have you taken any of the following herbs or over-the-counter medications in the last month? … Adjusted reductions in H-A1C (either baseline to lowest or baseline
to last) attenuated some of the … With these critical factors in mind, DARTNet is poised to undertake a rapid
expansion in the next 18 months